Ronifibrate

Ronifibrate
Clinical data
Other names	3-[(pyridin-3-yl)carbonyloxy]propyl 2-(4-chlorophenoxy)-2-methylpropanoate
ATC code	C10AB07 (WHO) ;
Identifiers
	IUPAC name 3-{[2-(4-chlorophenoxy)-2-methylpropanoyl]oxy}propyl nicotinate;
CAS Number	42597-57-9 ;
PubChem CID	68671;
ChemSpider	61925 ;
UNII	W86I18X716;
ChEMBL	ChEMBL153983 ;
CompTox Dashboard (EPA)	DTXSID80195362 ;
Chemical and physical data
Formula	C19H20ClNO5
Molar mass	377.82 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C(OCCCOC(=O)C(Oc1ccc(Cl)cc1)(C)C)c2cccnc2;
	InChI InChI=1S/C19H20ClNO5/c1-19(2,26-16-8-6-15(20)7-9-16)18(23)25-12-4-11-24-17(22)14-5-3-10-21-13-14/h3,5-10,13H,4,11-12H2,1-2H3 ; Key:AYJVGKWCGIYEAK-UHFFFAOYSA-N ;
	(what is this?) (verify)

Ronifibrate is a fibrate, a hypolipidemic agent. It is a combined ester of clofibric acid and niacin (nicotinic acid) with 1,3-propanediol. In the body, the ester is split to 1,3-propanediol and both acids which work in the same way, lowering lipids in blood.

References